ArticleJournal of experimental & clinical cancer research : CR2022

GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma.

Zhiqing Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.